Dermatological Drugs Market Size, Top Share And Regional Analysis by 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Dermatological Drugs Market Size Analysis

Global Dermatological Drugs Market Introduction
By Dermatological Diseases
1. Introduction
  1. Dermatological Diseases By Value
2. Acne
  1. By Value
3. Dermatitis
  1. By Value
4. Psoriasis
  1. By Value
5. Skin Cancer
  1. By Value
6. Others
  1. By Value
By Prescription Mode
1. Introduction
  1. Prescription Mode By Value
2. Prescription-Based Drugs
  1. By Value
3. Over-the-Counter Drugs
  1. By Value
By Drug Classification
1. Introduction
  1. Drug Classification By Value
2. Anti-Inflammatory & Antipruritic Drugs
  1. By Value
3. Corticosteroids
  1. By Value
4. Astringents
  1. By Value
5. Anti-Infective/Antibacterial Drugs
  1. By Value
6. Antifungal Drugs
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Topical
  1. By Value
3. Oral
  1. By Value
4. Parenteral Administration
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Speciality Clinics
  1. By Value
4. Cosmetic Centres
  1. By Value

North America Market Analysis

Introduction
By Dermatological Diseases
1. Introduction
  1. Dermatological Diseases By Value
2. Acne
  1. By Value
3. Dermatitis
  1. By Value
4. Psoriasis
  1. By Value
5. Skin Cancer
  1. By Value
6. Others
  1. By Value
By Prescription Mode
1. Introduction
  1. Prescription Mode By Value
2. Prescription-Based Drugs
  1. By Value
3. Over-the-Counter Drugs
  1. By Value
By Drug Classification
1. Introduction
  1. Drug Classification By Value
2. Anti-Inflammatory & Antipruritic Drugs
  1. By Value
3. Corticosteroids
  1. By Value
4. Astringents
  1. By Value
5. Anti-Infective/Antibacterial Drugs
  1. By Value
6. Antifungal Drugs
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Topical
  1. By Value
3. Oral
  1. By Value
4. Parenteral Administration
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Speciality Clinics
  1. By Value
4. Cosmetic Centres
  1. By Value
U.S.
1. By Dermatological Diseases
  1. Introduction
    1. Dermatological Diseases By Value
  2. Acne
    1. By Value
  3. Dermatitis
    1. By Value
  4. Psoriasis
    1. By Value
  5. Skin Cancer
    1. By Value
  6. Others
    1. By Value
2. By Prescription Mode
  1. Introduction
    1. Prescription Mode By Value
  2. Prescription-Based Drugs
    1. By Value
  3. Over-the-Counter Drugs
    1. By Value
3. By Drug Classification
  1. Introduction
    1. Drug Classification By Value
  2. Anti-Inflammatory & Antipruritic Drugs
    1. By Value
  3. Corticosteroids
    1. By Value
  4. Astringents
    1. By Value
  5. Anti-Infective/Antibacterial Drugs
    1. By Value
  6. Antifungal Drugs
    1. By Value
4. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Topical
    1. By Value
  3. Oral
    1. By Value
  4. Parenteral Administration
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Retail Pharmacies
    1. By Value
  4. Online Pharmacies
    1. By Value
6. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Speciality Clinics
    1. By Value
  4. Cosmetic Centres
    1. By Value
Canada

Europe Market Analysis

Introduction
By Dermatological Diseases
1. Introduction
  1. Dermatological Diseases By Value
2. Acne
  1. By Value
3. Dermatitis
  1. By Value
4. Psoriasis
  1. By Value
5. Skin Cancer
  1. By Value
6. Others
  1. By Value
By Prescription Mode
1. Introduction
  1. Prescription Mode By Value
2. Prescription-Based Drugs
  1. By Value
3. Over-the-Counter Drugs
  1. By Value
By Drug Classification
1. Introduction
  1. Drug Classification By Value
2. Anti-Inflammatory & Antipruritic Drugs
  1. By Value
3. Corticosteroids
  1. By Value
4. Astringents
  1. By Value
5. Anti-Infective/Antibacterial Drugs
  1. By Value
6. Antifungal Drugs
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Topical
  1. By Value
3. Oral
  1. By Value
4. Parenteral Administration
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Speciality Clinics
  1. By Value
4. Cosmetic Centres
  1. By Value
U.K.
1. By Dermatological Diseases
  1. Introduction
    1. Dermatological Diseases By Value
  2. Acne
    1. By Value
  3. Dermatitis
    1. By Value
  4. Psoriasis
    1. By Value
  5. Skin Cancer
    1. By Value
  6. Others
    1. By Value
2. By Prescription Mode
  1. Introduction
    1. Prescription Mode By Value
  2. Prescription-Based Drugs
    1. By Value
  3. Over-the-Counter Drugs
    1. By Value
3. By Drug Classification
  1. Introduction
    1. Drug Classification By Value
  2. Anti-Inflammatory & Antipruritic Drugs
    1. By Value
  3. Corticosteroids
    1. By Value
  4. Astringents
    1. By Value
  5. Anti-Infective/Antibacterial Drugs
    1. By Value
  6. Antifungal Drugs
    1. By Value
4. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Topical
    1. By Value
  3. Oral
    1. By Value
  4. Parenteral Administration
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Retail Pharmacies
    1. By Value
  4. Online Pharmacies
    1. By Value
6. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Speciality Clinics
    1. By Value
  4. Cosmetic Centres
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Dermatological Diseases
1. Introduction
  1. Dermatological Diseases By Value
2. Acne
  1. By Value
3. Dermatitis
  1. By Value
4. Psoriasis
  1. By Value
5. Skin Cancer
  1. By Value
6. Others
  1. By Value
By Prescription Mode
1. Introduction
  1. Prescription Mode By Value
2. Prescription-Based Drugs
  1. By Value
3. Over-the-Counter Drugs
  1. By Value
By Drug Classification
1. Introduction
  1. Drug Classification By Value
2. Anti-Inflammatory & Antipruritic Drugs
  1. By Value
3. Corticosteroids
  1. By Value
4. Astringents
  1. By Value
5. Anti-Infective/Antibacterial Drugs
  1. By Value
6. Antifungal Drugs
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Topical
  1. By Value
3. Oral
  1. By Value
4. Parenteral Administration
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Speciality Clinics
  1. By Value
4. Cosmetic Centres
  1. By Value
China
1. By Dermatological Diseases
  1. Introduction
    1. Dermatological Diseases By Value
  2. Acne
    1. By Value
  3. Dermatitis
    1. By Value
  4. Psoriasis
    1. By Value
  5. Skin Cancer
    1. By Value
  6. Others
    1. By Value
2. By Prescription Mode
  1. Introduction
    1. Prescription Mode By Value
  2. Prescription-Based Drugs
    1. By Value
  3. Over-the-Counter Drugs
    1. By Value
3. By Drug Classification
  1. Introduction
    1. Drug Classification By Value
  2. Anti-Inflammatory & Antipruritic Drugs
    1. By Value
  3. Corticosteroids
    1. By Value
  4. Astringents
    1. By Value
  5. Anti-Infective/Antibacterial Drugs
    1. By Value
  6. Antifungal Drugs
    1. By Value
4. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Topical
    1. By Value
  3. Oral
    1. By Value
  4. Parenteral Administration
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Retail Pharmacies
    1. By Value
  4. Online Pharmacies
    1. By Value
6. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Speciality Clinics
    1. By Value
  4. Cosmetic Centres
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Dermatological Diseases
1. Introduction
  1. Dermatological Diseases By Value
2. Acne
  1. By Value
3. Dermatitis
  1. By Value
4. Psoriasis
  1. By Value
5. Skin Cancer
  1. By Value
6. Others
  1. By Value
By Prescription Mode
1. Introduction
  1. Prescription Mode By Value
2. Prescription-Based Drugs
  1. By Value
3. Over-the-Counter Drugs
  1. By Value
By Drug Classification
1. Introduction
  1. Drug Classification By Value
2. Anti-Inflammatory & Antipruritic Drugs
  1. By Value
3. Corticosteroids
  1. By Value
4. Astringents
  1. By Value
5. Anti-Infective/Antibacterial Drugs
  1. By Value
6. Antifungal Drugs
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Topical
  1. By Value
3. Oral
  1. By Value
4. Parenteral Administration
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Speciality Clinics
  1. By Value
4. Cosmetic Centres
  1. By Value
UAE
1. By Dermatological Diseases
  1. Introduction
    1. Dermatological Diseases By Value
  2. Acne
    1. By Value
  3. Dermatitis
    1. By Value
  4. Psoriasis
    1. By Value
  5. Skin Cancer
    1. By Value
  6. Others
    1. By Value
2. By Prescription Mode
  1. Introduction
    1. Prescription Mode By Value
  2. Prescription-Based Drugs
    1. By Value
  3. Over-the-Counter Drugs
    1. By Value
3. By Drug Classification
  1. Introduction
    1. Drug Classification By Value
  2. Anti-Inflammatory & Antipruritic Drugs
    1. By Value
  3. Corticosteroids
    1. By Value
  4. Astringents
    1. By Value
  5. Anti-Infective/Antibacterial Drugs
    1. By Value
  6. Antifungal Drugs
    1. By Value
4. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Topical
    1. By Value
  3. Oral
    1. By Value
  4. Parenteral Administration
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Retail Pharmacies
    1. By Value
  4. Online Pharmacies
    1. By Value
6. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Speciality Clinics
    1. By Value
  4. Cosmetic Centres
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Dermatological Diseases
1. Introduction
  1. Dermatological Diseases By Value
2. Acne
  1. By Value
3. Dermatitis
  1. By Value
4. Psoriasis
  1. By Value
5. Skin Cancer
  1. By Value
6. Others
  1. By Value
By Prescription Mode
1. Introduction
  1. Prescription Mode By Value
2. Prescription-Based Drugs
  1. By Value
3. Over-the-Counter Drugs
  1. By Value
By Drug Classification
1. Introduction
  1. Drug Classification By Value
2. Anti-Inflammatory & Antipruritic Drugs
  1. By Value
3. Corticosteroids
  1. By Value
4. Astringents
  1. By Value
5. Anti-Infective/Antibacterial Drugs
  1. By Value
6. Antifungal Drugs
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Topical
  1. By Value
3. Oral
  1. By Value
4. Parenteral Administration
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Hospital Pharmacies
  1. By Value
3. Retail Pharmacies
  1. By Value
4. Online Pharmacies
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Speciality Clinics
  1. By Value
4. Cosmetic Centres
  1. By Value
Brazil
1. By Dermatological Diseases
  1. Introduction
    1. Dermatological Diseases By Value
  2. Acne
    1. By Value
  3. Dermatitis
    1. By Value
  4. Psoriasis
    1. By Value
  5. Skin Cancer
    1. By Value
  6. Others
    1. By Value
2. By Prescription Mode
  1. Introduction
    1. Prescription Mode By Value
  2. Prescription-Based Drugs
    1. By Value
  3. Over-the-Counter Drugs
    1. By Value
3. By Drug Classification
  1. Introduction
    1. Drug Classification By Value
  2. Anti-Inflammatory & Antipruritic Drugs
    1. By Value
  3. Corticosteroids
    1. By Value
  4. Astringents
    1. By Value
  5. Anti-Infective/Antibacterial Drugs
    1. By Value
  6. Antifungal Drugs
    1. By Value
4. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Topical
    1. By Value
  3. Oral
    1. By Value
  4. Parenteral Administration
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Hospital Pharmacies
    1. By Value
  3. Retail Pharmacies
    1. By Value
  4. Online Pharmacies
    1. By Value
6. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Speciality Clinics
    1. By Value
  4. Cosmetic Centres
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Dermatological Drugs Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Dr Reddy’s
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Bayer Pharmaceuticals
Johnson & Johnson Inc
Cadila Healthcare
Cipla
GlaxoSmithKline
Glenmark Pharmaceuticals Limited
L’Oreal SA
Lupin Limited
Pfizer Inc. (Pfizer)
Merck Group Chemicals
AbbVie Inc. (AbbVie)
Abbott Laboratories
Taro Pharmaceutical Industries Ltd
Roche Holding AG (Roche)
Sun Pharmaceutical Industries Limited
Sanofi Pasteur Pharmaceutical
Bristol-Myers Squibb
Takeda Pharmaceutical Company Limited.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Mitiksha Koul

Research Associate